Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Accueil  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Daniel E. Geffken founded Danforth Advisors LLC. Currently, Mr. Geffken occupies the position of Co-Managing Director at Danforth Advisors LLC, Chief Financial Officer at GenePeeks, Inc., Chief Financial Officer of Lysosomal Therapeutics, Inc., Chief Financial Officer at Apic Bio, Inc., Chief Financial Officer at Locust Walk Acquisition Corp. and Chief Financial Officer for ProMIS Neurosciences, Inc.

He is also on the board of Windtree Therapeutics, Inc., Elicio Therapeutics, Inc. and SG DAN Holdings LLC.

Daniel E. Geffken previously occupied the position of Chief Operating Officer at Seaside Therapeutics LLC, Chief Financial Officer & Senior Vice President at Codon Devices, Inc., Principal Accounting Officer & Controller at Gelesis, Inc., Chief Financial Officer for Apellis Pharmaceuticals, Inc., Chief Financial Officer at Sideris Pharmaceuticals, Inc., Chief Financial Officer of Adhera Therapeutics, Inc., Chief Financial Officer for Cidara Therapeutics, Inc., Chief Financial Officer at Homology Medicines, Inc., Chief Financial Officer of Cabaletta Bio, Inc., Chief Financial Officer of Stealth BioTherapeutics Corp., Chief Financial Officer at Transkaryotic Therapies, Inc. and Chief Financial Officer for Novira Therapeutics, Inc.

He received an MBA from Harvard Business School and an undergraduate degree from The Wharton School of the University of Pennsylvania.


Current positions of Daniel E. Geffken 
NameTitle Since
Locust Walk Acquisition Corp.
(Investment Holding Companies)
Chief Financial Officer 2020
Windtree Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2019
ProMIS Neurosciences, Inc.
(Biotechnology & Medical Research)
Chief Financial Officer 2017
CalciMedica, Inc. Chief Financial Officer 2020
Artax Biopharma, Inc. Chief Financial Officer -
Windgap Medical, Inc. Chief Financial Officer -
Zikani Therapeutics, Inc. Chief Financial Officer 2019
Nemucore Medical Innovations, Inc. Chief Financial Officer -
GenePeeks, Inc. Chief Financial Officer -
Vigeo Therapeutics, Inc. Chief Financial Officer 2017
United Neuroscience Ltd. Chief Financial Officer -
Antolrx, Inc. Chief Financial Officer 2016
Palvella Therapeutics, Inc. Chief Financial Officer 2020
DermBiont, Inc. Chief Financial Officer 2020
Clear Creek Bio, Inc. Chief Financial Officer -
Apnimed, Inc. Chief Financial Officer -
Apic Bio, Inc. Chief Financial Officer 2018
Privo Technologies, Inc. Chief Financial Officer 2020
Prilenia Therapeutics Development Ltd. Chief Financial Officer -
Matrivax Research & Development Corp. Chief Financial Officer -
Elicio Therapeutics, Inc. Chief Financial Officer & Director 2014
SG DAN Holdings LLC Director -
Danforth Advisors LLC Co-Managing Director 2011


Holdings of Daniel E. Geffken 
NameEquities%Valuation
Windtree Therapeutics, Inc. (WINT)
(Biotechnology & Medical Research)
2,0690.012%11,524 USD
Graybug Vision, Inc. (GRAY)
(Biotechnology & Medical Research)
00.0000%0 USD
Atea Pharmaceuticals, Inc. (AVIR)
(Biotechnology & Medical Research)
00.0000%0 USD


Daniel E. Geffken: Personal Network 
Most Read News 
02/25ELON MUSK : Tesla's Musk says U.S. factory closed for two days due to parts shortages
RE
02/20ELON MUSK : Bitcoin and ethereum prices 'seem high,' says Musk
RE
02/23MICHAEL KLEIN : Tesla rival Lucid Motors to go public in $24-billion mega SPAC deal
RE
02/16MICHAEL KLEIN : Lucid Motors nears SPAC deal as Klein launches financing - sources
RE
02/27WARREN BUFFETT : Warren Buffett's Berkshire Hathaway Sees Profit Rise 23%--2nd Update
DJ
02/15BILL GATES : Bill Gates warns that manufacturing could challenge climate goals
RE
02/16WARREN BUFFETT : Buffett's Berkshire Hathaway Bets Billions on Verizon and Chevron
DJ
02/24CARL ICAHN : Under eye of Icahn, Bausch Health gives activist investor two board seats
RE
02/27WARREN BUFFETT : Buffett upbeat on U.S. and Berkshire, buys back stock even as pandemic hits results
RE
02/14EMMANUEL FABER : Artisan Partners to meet Danone board members next week
RE
More news


© 2021 People and Ownership :   
Daniel E. Geffken : Connections 



Popular Business Leaders 
Bernard Arnault Jeff Bezos Vincent Bolloré Alexandre Bompard Martin Bouygues Thierry Breton Warren Buffett Hubert Burda Francesco Gaetano Caltagirone Bertrand Camus Jean-charles Decaux Jack Dorsey Axel Dumas Emmanuel Faber Henrik Fisker Antoine Frérot Bill Gates Philip Green Luigi Gubitosi Yves Guillemot Paul Hudson Carl Icahn Jan Jenisch Michael Klein Hariolf Kottmann Arnaud Lagardère Johan Lundgren Jean-bernard Lévy Jack Ma Lakshmi Mittal Elon Musk Jean-pierre Mustier Nicolas Namias David Nicol Xavier Niel Yves Perrier Patrick Pouyanné Alexandre Ricard Charles Scharf Gilles Schnepp Christian Sewing Feike Sijbesma Arne Sorenson Osamu Suzuki Heinz Hermann Thiele François Villeroy De Galhau David Wichmann Mark Zuckerberg Pierre-andré De Chalendar Ranieri De Marchis
A-Z Business Leaders